Platform Technology Partners’s Gilead Sciences GILD Stock Holding History

Platform Technology Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$343K	Sell	2,716 -563	-17%	-$74.2K	0.06%	232
2026 Q1	$457K	Buy	3,279 +592	+22%	+$82.9K	0.09%	173
2025 Q4	$330K	Buy	2,687 +53	+2%	+$6.44K	0.07%	195
2025 Q3	$292K	Sell	2,634 -2,892	-52%	-$329K	0.07%	201
2025 Q2	$613K	Buy	+5,526	New	+$588K	0.16%	129
2021 Q3	–	Sell	-3,333	Closed	-$230K	–	252
2021 Q2	$230K	Buy	+3,333	New	+$223K	0.09%	215
2020 Q4	–	Sell	-4,937	Closed	-$312K	–	244
2020 Q3	$312K	Buy	4,937 +1,247	+34%	+$86.5K	0.19%	129
2020 Q2	$284K	Buy	+3,690	New	+$283K	0.2%	136

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Platform Technology Partners's GILD Position: Q2 2026 in Review

Platform Technology Partners reduced its Gilead Sciences (GILD) stake by 17% in Q2 2026, selling an estimated $74.2K and leaving 2,716 shares worth $343K. The position accounts for 0.06% of the portfolio, ranked #232.

Platform Technology Partners first reported a position in GILD in Q2 2020 and has held it in 8 quarters since. The position peaked at $613K in Q2 2025. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Platform Technology Partners held 2,716 shares of Gilead Sciences worth $343K as of Q2 2026.
Platform Technology Partners sold 563 Gilead Sciences shares in Q2 2026, an estimated $74.2K.
Gilead Sciences made up 0.06% of Platform Technology Partners's portfolio in Q2 2026, its #232 holding.
Platform Technology Partners first reported a position in Gilead Sciences in Q2 2020 and has held it in 8 quarters since.
Platform Technology Partners's Gilead Sciences position peaked at $613K in Q2 2025.
2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Platform Technology Partners's 13F filing for Q2 2026, filed 24 Jul 2026.